Welcome to CD Formulation
Products
Finasteride
Product Details
Molecular Formula
C23H36N2O2
Appearance
Solid
Grade
GMP
Description
Finasteride is a basic drug for the treatment of prostatic hyperplasia and prostatitis in China. It is a synthetic 4-nitrosteric hormone compound and a resistant hormone drug. It can selectively inhibit 5α - reductase, inhibit the process of transforming testosterone into 5α - dihydrotestosterone (DHT), and reduce the level of androgen Chemicalbook in prostate cells. Serum prostate-specific antigen decreased, enlarged prostate volume decreased, urine flow rate increased, thereby reducing the symptoms of patients, to achieve the purpose of treating prostate hyperplasia. The action of the drug is characterized by the selective blocking of androgen stimulation of the prostate gland, but it rarely affects the sexual function of men.
CAS Number
98319-26-7
Solubility
DMSO: 32 mg/mL, soluble
Storage
room temp
Applications
Finasteride is a specific inhibitor of intracellular enzyme type II 5A-reductase in the process of testosterone metabolism to dihydrotestosterone, which can effectively reduce the dihydrotestosterone in the blood and prostate, that is, by inhibiting the conversion of testosterone into dihydrotestosterone (DHT), reduce the size of the prostate, improve symptoms, increase urine flow rate, and prevent benign prostatic hyperplasia (BPH).
Boiling Point
576.6±50.0 °C(Predicted)
Melting Point
253 °C
Density
1.065±0.06 g/cm3(Predicted)
EC Number
620-534-3
Molecular Weight (g/mol)
372.54
Physical State
solid
HS Code
29379000
Color
white to beige
Online Inquiry
Please note: Our products and services are not intended to be used directly in diagnostic or therapeutic procedures.
GET IN TOUCH
Enter your email here to subscribe.
Easy access to products and services you need from our library via powerful searching tools.